In QuotedData’s morning briefing 31 December 2021:
- International Biotechnology Trust (IBT) will invest in SV Health Investors (the manager)’s forthcoming biotechnology focused private fund, SV Biotech Crossover Opportunities Fund LP. The trust tries to keep its exposure to unquoted stocks between 5% and 15% of its portfolio.
- Murray International (MYI) says that, with effect from 1 January 2022, its management fee will be 0.5% of NAV up to £500m and 0.4% of NAV above that figure. That compares to an existing fee of 0.5% of NAV up to £1,200m and 0.425% thereafter.
In addition, Round Hill Music has made a couple of new investments
We’d like to take this opportunity to wish all our readers a very happy New Year